Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Molecular Execs Consider Sale of Company, GCG’s Devereux Retires



XFORD, UK--Executives at Oxford Molecular have acknowledged that they and their advisors, Donaldson Lufkin & Jenrette International, are considering a sale of the company. The company last month announced 1999 losses of £26 million and plans to cut 55 jobs.

James Hiddleston, a company director here, told BioInform that Oxford Molecular’s bioinformatics business has been expanding and that a new strategy calls for concentrating resources on development of drug discovery software.

Anthony Grass, vice-president for marketing and communications, added that although a sale of the company is one option being considered, it is not a preferred strategy. "The real story is we are concentrating on life sciences and pharmaceutical markets and we are consolidating to do that better," he said.

Toward that end, Hiddleston said that Oxford Molecular’s UK bioinformatics staff has been relocated to Madison, Wis., the headquarters of Genetics Computer Group, a wholly owned subsidiary of Oxford Molecular.

John Devereux, who founded Genetics Computer Group in 1982 and is considered a bioinformatics industry pioneer, recently retired. Matteo di Tommaso, who developed the company’s SeqStore data management product and previously headed database development at the European Bioinformatics Institute, has been appointed general manager. Devereux will continue to work as a consultant to the company.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.